Activity Objectives:

Qualifying Cord Blood Products for Legitimate Applications is organized by American Association of Blood Banks (AABB) and will be held from Aug 08, 2019 - Jun 03, 2022. This Conference has been approved for a maximum of 1.00 continuing education credits/contact hours.

Intended Audience: 
Directors, Donor Recruitment Staff, Hospitals, Hospital Blood Banks, Laboratory Staff, Managers/Supervisors, Medical Directors, Nurses, Physicians, Research Scientists, Resident/Fellow, Scientists, Technologists.

Topic: Cellular Therapies

Program Description:
Questions arise as to the safety and traceability of cord blood products sold to third parties. This program will address how to qualify or approve research grade cord blood products for sale to companies. In addition, legal and regulatory questions arise in Private Banking when there are requests to release CT products for unproven clinical Autologous/Family Directed uses. This eCast will include discussion of SOPs designed to determine if cord and CT products will be used for legitimate purposes -- not for ‘unproven clinical work.’

Learning Objectives:
After participating in this educational activity, participants should be able to:
• Identify points to consider in determining appropriate customers for sale of cord blood products.
• Discuss criteria to ensure appropriate handling of cord blood products.
• Describe SOPs designed to determine if cord and CT products will be used for legitimate purposes.

Additional details will be posted as soon as they are available.

Intended Audience

Biotechnology, Research and Clinical Research

Activity Payment Details

Activity Fee : USD $65.00

Rate this CME (Min 1 - Max 5)

Fee and expenses:
CME credits:
Program contents:
Write Your Review

Reviews Given by Professionals

No Reviews available. Be the first to write a review.

Privacy Policy

Read eMedEvents Privacy Policy


American Association of Blood Banks (AABB)

View Organizer Details